In the thick of it: HCM-causing mutations in myosin binding proteins of the thick filament

Samantha P. Harris, Ross G. Lyons, Kristina L. Bezold

Research output: Contribution to journalArticle

121 Scopus citations

Abstract

In the 20 years since the discovery of the first mutation linked to familial hypertrophic cardiomyopathy (HCM), an astonishing number of mutations affecting numerous sarcomeric proteins have been described. Among the most prevalent of these are mutations that affect thick filament binding proteins, including the myosin essential and regulatory light chains and cardiac myosin binding protein (cMyBP)-C. However, despite the frequency with which myosin binding proteins, especially cMyBP-C, have been linked to inherited cardiomyopathies, the functional consequences of mutations in these proteins and the mechanisms by which they cause disease are still only partly understood. The purpose of this review is to summarize the known disease-causing mutations that affect the major thick filament binding proteins and to relate these mutations to protein function. Conclusions emphasize the impact that discovery of HCM-causing mutations has had on fueling insights into the basic biology of thick filament proteins and reinforce the idea that myosin binding proteins are dynamic regulators of the activation state of the thick filament that contribute to the speed and force of myosin-driven muscle contraction. Additional work is still needed to determine the mechanisms by which individual mutations induce hypertrophic phenotypes.

Original languageEnglish (US)
Pages (from-to)751-764
Number of pages14
JournalCirculation research
Volume108
Issue number6
DOIs
StatePublished - Mar 18 2011

    Fingerprint

Keywords

  • hypertrophic cardiomyopathy
  • myosin binding protein-C
  • myosin essential light chain
  • myosin regulatory light chain

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine

Cite this